These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 13325651)

  • 1. [Clinical significance of intravenous iron addition. II. Elimination rate of intravenously administered iron in chronic disorders of liver parenchyma and liver cirrhosis].
    REICHENBERGER J; HEVELKE G
    Z Gesamte Inn Med; 1956 Mar; 11(5):204-8. PubMed ID: 13325651
    [No Abstract]   [Full Text] [Related]  

  • 2. [The blood serum iron level in chronic hepatitis and cirrhosis of the liver].
    Zikeeva VK
    Klin Med (Mosk); 1965 Nov; 43(11):53-8. PubMed ID: 5874303
    [No Abstract]   [Full Text] [Related]  

  • 3. Serum iron parameters in patients with alcoholic and chronic cirrhosis and hepatitis.
    Jurczyk K; Wawrzynowicz-Syczewska M; Boroń-Kaczmarska A; Sych Z
    Med Sci Monit; 2001; 7(5):962-5. PubMed ID: 11535942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Iron turnover in chronic hepatitis.
    Burger T; Pár A; Gógl A; Schmelzer M
    Acta Med Acad Sci Hung; 1976; 33(1):1-11. PubMed ID: 1023735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical evaluation of the serum iron level in chronic hepatitis].
    Zikeeva VK
    Sov Med; 1965 Sep; 28(9):52-7. PubMed ID: 5871699
    [No Abstract]   [Full Text] [Related]  

  • 6. [Relations among blood sedimentation rate, alpha-2 and gamma globulins and fibrinogen in acute viral hepatitis, cirrhosis and chronic hepatitis].
    Nuhoglu A; Bolükoglu MA; Aküzümcü O; Goksel V
    Rev Med Moyen Orient; 1967; 24(3):220-5. PubMed ID: 4180032
    [No Abstract]   [Full Text] [Related]  

  • 7. [Plasma tyrosine level in liver diseases].
    Selmair H; Langness U; Zimmermann J; Herborn U
    Med Klin; 1971 Jun; 66(30):1049-52. PubMed ID: 5569262
    [No Abstract]   [Full Text] [Related]  

  • 8. [Studies on the quantitative, morphological and functional changes of the thrombocytes in chronic liver diseases].
    KORINTH E
    Acta Hepatosplenol; 1962 Apr; 9():65-73. PubMed ID: 14458420
    [No Abstract]   [Full Text] [Related]  

  • 9. [Behavior of serum glutamic oxalacetic transaminase in chronic recurrent hepatitis and active posthepatitis liver cirrhosis under prednisone therapy; preliminary report].
    LINDNER H
    Klin Wochenschr; 1958 Sep; 36(18):877-8. PubMed ID: 13588932
    [No Abstract]   [Full Text] [Related]  

  • 10. Protein-lipid relationships in human plasma: in biliary cirrhosis, obstructive jaundice, and acute hepatitis.
    EDER HA; RUSS EM; PRITCHETT RA; WILBER MM; BARR DP
    J Clin Invest; 1955 Jul; 34(7, Part 1):1147-62. PubMed ID: 14392229
    [No Abstract]   [Full Text] [Related]  

  • 11. Serum iron parameters in cirrhosis and chronic hepatitis: detailed description.
    Büyükaşik NS; Nadır I; Akin FE; Cakal B; Kav T; Ersoy O; Büyükaşik Y
    Turk J Gastroenterol; 2011 Dec; 22(6):606-11. PubMed ID: 22287406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The serum prealbumin significance in differential diagnosis of the liver diseases (author's transl)].
    Gróza S
    Med Klin; 1976 Feb; 71(9):378-9. PubMed ID: 1256337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Significance of serum triglycerides, nonesterified fatty acids and phospholipids in acute and chronic hepatitis].
    Torjescu V; Ceauşu E; Văleanu M; Pîrvu D; Melencu M; Urcan M
    Med Interna (Bucur); 1968 Jul; 20(7):817-23. PubMed ID: 5685312
    [No Abstract]   [Full Text] [Related]  

  • 14. [Changes in the bilirubin fractions in the acute and chronic hepatitis and liver cirrhosis (Eberlaine's technique)].
    Sokolova GM
    Klin Med (Mosk); 1970 Jan; 48(1):96-102. PubMed ID: 5419575
    [No Abstract]   [Full Text] [Related]  

  • 15. [Experimental and clinical studies on ferro-and erythrokinetics in hepatic fibrosis].
    Shiraishi T
    Rinsho Ketsueki; 1972 Aug; 13(4):455-7. PubMed ID: 4674838
    [No Abstract]   [Full Text] [Related]  

  • 16. [The daily variations in serum iron and latent iron binding capacity in hepatitis, liver cirrhosis, alcoholism, hemochromatosis and aplastic anemia].
    Speck B
    Schweiz Med Wochenschr; 1970 Feb; 100(7):303-5. PubMed ID: 5413919
    [No Abstract]   [Full Text] [Related]  

  • 17. [Significance of serum iron in hepatitis].
    CHILOV K; GOSPODINOVA V
    Izv Meditsinskite Inst Bulg Akad Naukite Sofia Otd Biol Meditsinski Nauki; 1955; 11-12():89-102. PubMed ID: 13262947
    [No Abstract]   [Full Text] [Related]  

  • 18. [Immuno-electrophoresis of the blood serum in the cirrhotic and alcoholic hepatic patient. Documentary study of 68 cases].
    VERAIN M; COLLESSON L; FRENTZ R; GRILLIAT JP
    Pathol Biol; 1961 Nov; 9():2087-92. PubMed ID: 13925365
    [No Abstract]   [Full Text] [Related]  

  • 19. [Iron-binding capacity of blood serum. II. Behavior of the iron-binding capacity in liver cirrhosis and hemochromatosis].
    RECHENBERGER J
    Dtsch Z Verdau Stoffwechselkr; 1956; 16(4):155-62. PubMed ID: 13344137
    [No Abstract]   [Full Text] [Related]  

  • 20. On status of serum iron parameters in chronic hepatitis and cirrhosis: comments on the article by Mao et al.
    Buyukasik NS; Buyukasik Y
    Eur J Gastroenterol Hepatol; 2015 Apr; 27(4):476. PubMed ID: 25874527
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.